Translation and cultural adaptation to portuguese of a quality of life questionnaire for patients with melasma

Tania Ferreira Cestari; Rajesh Balkrishann; Magda Blessmann Weber; Clarissa Prati; Doris Baratz Menegon; Nicolle Gollo Mazzotti; Carina Troian

2006, Number 6

<< Back Next >>

Med Cutan Iber Lat Am 2006; 34 (6)

Translation and cultural adaptation to portuguese of a quality of life questionnaire for patients with melasma

Ferreira CT, Balkrishann R, Blessmann WM, Prati C, Baratz MD, Gollo MN, Troian C

Full text

How to cite this article

Language: English
References: 21
Page: 270-274
PDF size: 158.73 Kb.

Text Extraction

Dermatoses, mainly those with important esthetic involvement, can produce a significant impact in the social, familiar and professional life of patients. Among these diseases, melasma is distinguished by its relapsing hyperchromic macules, with disappointing therapeutic results. Considering all these features, besides the objective evaluation of the therapeutic results, the dimension of the disease influence on the quality of life is considered of similar relevance. This influence is measured by validated questionnaires, most of them written in English. Its translation and cultural adaptation are necessary steps before being applied to people whom speak other languages. This study describes the translation and adaptation to Portuguese of the quality of life questionnaires developed for patients with Melasma (MELASQoL), according to the rules established by the World Health Organization. In summary: two independent literal translations to Portuguese; review by a health professionals bilingual group; application of the first version to 10 volunteer patients that agreed to report their opinion; discussion of items and administration procedures; back-translation to English; evaluation by the original author; review by the bilingual group and formatting of the final Portuguese questionnaire. The version and routine application of the MELASQoL instrument will allow a significant improvement on the individual evaluations as well as the participation on multi center studies, produ- cing consistent and comparable results.

REFERENCES

Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994;272:619-26.
2.Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
4.Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997;136:305-14.
5.Fleck M, Leal O, Louzada S, Xavier M, Chacha-movich E, Vieira G, et al. Desenvolvimento da versão em português do instrumento de avaliação de qualidade de vida da OMS (WHOQOL- 100). Rev Bras Psiquiatr 1999;21:19-28.
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417- 32.
Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. A new instrument for assessing quality of life in a topic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 2004;150:274-83.
De Korte J, Mombers FM, Sprangers MA, Bos JD. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002; 138:1221-7.
McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, et al. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 2003;149:323-31.
Halioua B, Beumont MG, Lunel F. Quality of life in dermatology. Int J Dermatol 2000; 39:801-6.
11.Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ. Health-related quality of life among patients with facial acne-assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001;26:380-5.
Kadyk DL, McCarter K, Achen F, Belsito DV. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol 2003;49:1037-48.
13.Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol 2003; 148:373-4.
14.Skoet R, Zachariae R, Agner T. Contact dermatitis and quality of life: a structured review of the literature. Br J Dermatol 2003;149: 452-6.
15.Im S, Hann S-K, Kang WH. Melasma. In Im S, Hann S-K, Kang WH, eds. New Concept of Melasma and Postinflammatory Hyperpigmentation, pp. 29-176, 2002.
Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol 1995;131:1453-7.
17.Ortonne JP. Photoprotective properties of skin melanin. Br J Dermatol 2002;146 (Supl. 61):7-10.
Pandya AG, Guevara IL. Disorders of hyper-pigmentation. Dermatol Clin 2000;18:91-8, ix.
19.Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 2003;16:101-10.
Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003;149:572-7.
21.Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001;5(2):105-10.